Evaluation of Superiority of Valsartan+Celecoxib+Metformin Over Metformin Alone in Type 2 Diabetes Patients

NCT03686657 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

NOT_YET_RECRUITING

Status

115

Enrollment

INDUSTRY

Sponsor class

Conditions

Type 2 Diabetes
High Blood Pressure
Arthritis
Obesity

Interventions

DRUG: Metformin
DRUG: Val, Cel and Met XR Low
DRUG: Val, Cel and Met XR High

Sponsor

ARKAY Therapeutics

Collaborators

[object Object]
[object Object]